Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abroad, AESTHETIC, Alike, arrive, ASX, attached, BA, bankruptcy, baseline, BATM, Battery, bedside, Bioscience, Birger, cap, Carlo, Catalyst, caution, Chase, Citrine, clarification, Clark, composed, computerized, confirmatory, constantly, CRISPR, CRO, CTGL, CV, dataset, DBN, de, decade, Deputy, Diagnostic, Digital, dismissal, dismissed, DMC, Doctoral, door, epidemiological, epidemiology, evolution, expended, Fellowship, fetal, Fitango, genetic, grown, guaranty, HAIR, heart, hemoglobin, Hera, Highcon, HMD, hybrid, ICCM, IceCure, IM, Imaging, induced, inflammation, Innovare, INSL, Insulin, Intelicanna, intersection, INTL, involuntary, IOPtima, Isr, JPMorgan, judicial, Kadimastem, KDST, Kesselman, KSM, lengthier, lesser, Levi, lineage, lsr, MA, Maccabi, Maccabitech, Magisto, Maital, massive, Matricelf, MCS, MD, Med, median, Mekorot, Monte, MPH, MST, neighboring, Netiv, neutrophil, noncancelable, notable, Nurami, Octave, Oracle, ordinary, OTC, pioneered, platelet, precise, PREPAID, Prof, professor, Rasmussen, real, reprograming, respectfully, rest, Roche, role, SA, secretion, settlement, Shalev, Shemesh, Sight, simulation, solution, SPPB, SRC, steady, step, STIMULATING, substantive, Surgical, TASE, technique, topline, Tourism, transfusion, transiently, trauma, Treasury, Ultrasight, underlying, unexpected, unexpectedly, Varda, verification, Vibrant, viewed, vital, Water
Removed:
accretion, advice, Africa, AFS, amortization, amortized, applicant, article, assume, assumed, attending, attribution, Binational, blind, breast, capable, clarified, classification, colorectal, commenced, confidence, confirmation, confirmed, consumed, consumption, COSO, coupon, decreased, diseased, double, efficient, employ, entrepreneurial, equality, equivalent, EU, expiring, FBR, female, Foundation, frequency, gender, grantor, grossed, HAEMATOPOIETIC, harboring, heal, honor, inclusive, ineffective, ineligible, inhibitory, intent, investigating, investigation, journal, judged, kidney, length, lessee, liver, lung, marketable, Meretzki, messaging, mice, MLV, Nachum, nonemployee, obliged, Oppenheimer, opposed, package, participated, paying, pooled, precede, prescribing, proliferation, Pronouncement, publication, realizable, reclassified, remeasured, remission, reside, restated, Rosman, satisfied, seniority, separated, shorten, skin, speculative, strong, sum, targeted, theoretical, thousand, today, triple, tumor, turn, underwriter, underwriting, unpatentable, unqualified, unrealized, veteran, wide, Yaky, Zami
Filing tables
Filing exhibits
- 10-K Annual report
- 10.18 Form of Restricted Share Unit Agreement Under the 2019 Equity Compensation Plan
- 10.19 Form of Restricted Share Unit Agreement (Israeli Directors and Officers) Under the 2019 Equity Compensation Plan
- 10.20 Form of Restricted Stock Unit Agreement (Employees) Under the 2019 Equity Compensation Plan
- 10.28 Letter Agreement by and Between Pluristem LTD. and Rose High Tech LTD., Dated September 13, 2021
- 10.29 Letter Agreement by and Between Pluristem LTD. and Yaky Yanay, Dated September 13, 2021
- 10.30 Letter Agreement by and Between Pluristem LTD. and Chen Franco-yehuda, Dated September 13, 2021
- 23.1 Consent of Kost Forer Gabbay & Kasierer, a Member of Ernst & Young Global
- 23.2 Consent of Kesselman & Kesselman, Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
PLUR similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
In connection with the Annual Report on Form 10-K of Pluristem Therapeutics Inc. (the “Company”) for the period ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350 that, to my knowledge:
1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: September 13, 2021
By: | /s/ Chen Franco-Yehuda | |
Chen Franco-Yehuda | ||
Chief Financial Officer |